Skip to main content
Michael Milone, MD, Pathology, Philadelphia, PA

MichaelCMiloneMD

Pathology Philadelphia, PA

Blood Banking & Transfusion Medicine, Anatomic Pathology, Clinical Pathology

Assistant Professor, Pathology & Laboratory Medicine, Perelman School of Medicine

Dr. Milone is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Milone's full profile

Already have an account?

  • Office

    3400 Spruce St
    Philadelphia, PA 19104
    Phone+1 215-662-6503

Education & Training

  • University of Pennsylvania Health System
    University of Pennsylvania Health SystemFellowship, Blood Banking/Transfusion Medicine, 2002 - 2003
  • University of Pennsylvania Health System
    University of Pennsylvania Health SystemResidency, Pathology-Anatomic and Clinical, 2000 - 2002
  • University of Pennsylvania Health System
    University of Pennsylvania Health SystemInternship, Internal Medicine, 1999 - 2000
  • Rutgers New Jersey Medical School
    Rutgers New Jersey Medical SchoolClass of 1999

Certifications & Licensure

  • PA State Medical License
    PA State Medical License 2002 - 2024
  • American Board of Pathology Clinical Pathology

Publications & Presentations

PubMed

Journal Articles

  • Efficacy and Safety of Hydroxychloroquine vs Placebo for Pre-Exposure SARS-CoV-2 Prophylaxis Among Health Care Workers  
    Matthew C Hyman, Ian Frank, Scott E Hensley, Saar Gill, Dan T Vogl, Ivan Maillard, Daria V Babushok, Alexander C Huang, Sunita D Nasta, Jennifer C Walsh, Michael C Mil..., JAMA Internal Medicine
  • CAR T Cell Immunotherapy for Human Cancer  
    Carl H June, Michael C Milone, Science Magazine
  • High-Affinity GD2-Specific CAR T Cells Induce Fatal Encephalitis in a Preclinical Neuroblastoma Model  
    Stephan A Grupp, Zissimos Mourelatos, Michael C Milone, David M Barrett, Sarah A Richman, Clinical Cancer Research

Lectures

  • Predictors of T Cell Expansion and Clinical Responses Following B-Cell Maturation Antigen-Specific Chimeric Antigen Receptor T Cell Therapy (CART-BCMA) for Relapsed/Re... 
    2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
  • PD-1 Inhibitor Combinations As Salvage Therapy for Relapsed/Refractory Multiple Myeloma (MM) Patients Progressing after Bcma-Directed CAR T Cells 
    2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
  • Clinical Predictors of T Cell Fitness for CAR T Cell Manufacturing and Efficacy in Multiple Myeloma 
    2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
  • Join now to see all

Press Mentions

  • Penn Medicine Breakthrough Immunotherapy Technique Could Reduce Cost of Cancer Treatment
    Penn Medicine Breakthrough Immunotherapy Technique Could Reduce Cost of Cancer TreatmentApril 12th, 2022
  • Research Roundup: Scientists May Have Solved CAR-T Turnaround Challenge
    Research Roundup: Scientists May Have Solved CAR-T Turnaround ChallengeApril 1st, 2022
  • FDA Approves Personalized Cellular Therapy for Advanced Leukemia Developed by University of Pennsylvania and Children’s Hospital of Philadelphia
    FDA Approves Personalized Cellular Therapy for Advanced Leukemia Developed by University of Pennsylvania and Children’s Hospital of PhiladelphiaAugust 30th, 2017
  • Join now to see all